In addition, COX-2 inhibitor (NS-398) or 5-LOX inhibitor (AA861) inhibits CRC tumor invasion and proliferation by promoting apoptosis through modulation of the PTEN/PI3K/Akt pathway 138. Here, PTGS2 is linked to neoplasm.